
Avient Corporation
NYSE•AVNT
CEO: Dr. Ashish K. Khandpur Ph.D.
セクター: Basic Materials
業種: Chemicals - Specialty
上場日: 1999-09-13
Avient Corporation operates as a formulator of material solutions in the United States, Canada, Mexico, Europe, South America, and Asia. It operates in two segments, Color, Additives and Inks; and Specialty Engineered Materials. The Color, Additives and Inks segment offers custom color and additive concentrates in solid and liquid form for thermoplastics, dispersions for thermosets, and specialty inks; custom-formulated liquid system, such as polyester, vinyl, natural rubber and latex, polyurethane, and silicone; and proprietary inks. Its products are used in medical and pharmaceutical devices, food packaging, personal care and cosmetics, transportation, building products, wire and cable, recreational and athletic apparel, construction and filtration, outdoor furniture, healthcare, textiles and appliances, and industrial markets. The Specialty Engineered Materials segment provides specialty polymer formulations, services, and solutions for designers, assemblers, and processors of thermoplastic materials. It sells its products through direct sales personnel, distributors, and commissioned sales agents. The company was formerly known as PolyOne Corporation and changed its name to Avient Corporation in June 2020. Avient Corporation was founded in 1885 and is headquartered in Avon Lake, Ohio.
連絡先情報
時価総額
$3.67B
PER (TTM)
32.4
20.3
配当利回り
2.7%
52週高値
$44.78
52週安値
$27.48
52週レンジ
順位50Top 68.9%
3.1
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
弱い • 3.1 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025
財務ダッシュボード
Q3 2025 データ
売上高
$806.50M-1.07%
直近4四半期の推移
EPS
$0.36-14.29%
直近4四半期の推移
フリーCF
$47.40M+2.82%
直近4四半期の推移
2025 Q3 決算ハイライト
主なハイライト
Nine Month Sales Growth Total sales reached $2.50B USD for nine months, a slight 0.2% increase over 2024, aided by favorable currency.
Operating Income Significantly Lower Operating income fell 32.7% to $163.9M USD for nine months, impacted by $71.6M ERP impairment charge.
Net Income Declines Sharply Net income attributable to common shareholders dropped 46.4% to $65.0M USD for the nine months ended September 30, 2025.
Long-Term Debt Reduced Long-term net debt decreased to $1.97B USD as $100.0M voluntary prepayment was made on senior secured term loan.
リスク要因
ERP Impairment Pressure $71.6M non-cash impairment charge recognized for S/4HANA cessation, severely pressuring nine-month operating results.
Environmental Liability Exposure Environmental accruals total $144.5M USD; potential for material additional costs exists based on future testing findings.
Foreign Trade Policy Shifts Changes in tariffs and trade regulations could materially affect operating results across key international markets.
Restructuring Charge Execution Clariant integration restructuring incurred $64.3M incurred of expected $66.0M charges, impacting current period profitability.
見通し
Debt Management Strategy Refinanced senior term loan in March 2025, reducing interest rate by 25 basis points; covenants currently compliant.
Liquidity Position Strong Liquidity totals $932.9M USD, sufficient for expected uses including debt prepayments and capital expenditures through 2025.
Restructuring Completion Expected Full Clariant Color integration restructuring plan completion anticipated by the end of fiscal year 2025.
Evaluating New Accounting Rules Currently evaluating FASB ASU 2023-09 regarding income tax disclosures, effective for fiscal years beginning after 2024.
同業比較
売上高 (TTM)
$6.78B
$6.58B
AXTA$5.12B
粗利益率 (最新四半期)
58.3%
WDFC56.2%
ESI42.2%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| ESI | $7.80B | 32.5 | 9.4% | 32.2% |
| AVTR | $7.61B | -92.6 | -1.4% | 33.0% |
| AXTA | $7.34B | 19.4 | 16.9% | 0.3% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
2.6%
緩やかな成長
4四半期純利益CAGR
-12.3%
収益性の低下
キャッシュフロー安定性
75%
キャッシュフローの変動が大きい
深度リサーチ
次回決算:2026年2月12日
EPS:$0.55
|売上高:$748.16M
財務レポート
財務データ
全年度
Form 10-Q - Q3 2025
会計期末: 2025年9月30日|提出日: 2025年11月5日|売上高: $806.50M-1.1%|EPS: $0.36-14.3%予想を下回るForm 10-Q - Q2 2025
会計期末: 2025年6月30日|提出日: 2025年8月1日|売上高: $866.50M+2.0%|EPS: $0.57+54.1%予想を下回るForm 10-Q - Q1 2025
会計期末: 2025年3月31日|提出日: 2025年5月6日|売上高: $826.60M-0.3%|EPS: $-0.22-140.7%予想を下回るForm 10-K - FY 2024
会計期末: 2024年12月31日|提出日: 2025年2月18日|売上高: $3.24B+3.1%|EPS: $1.86+124.1%予想を上回るForm 10-Q - Q3 2024
会計期末: 2024年9月30日|提出日: 2024年11月5日|売上高: $815.20M+8.2%|EPS: $0.42+650.0%予想を下回るForm 10-Q - Q2 2024
会計期末: 2024年6月30日|提出日: 2024年8月6日|売上高: $849.70M+3.1%|EPS: $0.37+54.2%予想を下回るForm 10-Q - Q1 2024
会計期末: 2024年3月31日|提出日: 2024年5月7日|売上高: $829.00M-2.0%|EPS: $0.54+145.5%予想を下回るForm 10-K - FY 2023
会計期末: 2023年12月31日|提出日: 2024年2月20日|売上高: $3.14B-7.5%|EPS: $0.83-50.6%予想を上回る